BMI1 and Mel-18 Oppositely Regulate Carcinogenesis and Progression of Gastric Cancer

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2010 Feb 23

PMID 20170541

Citations 58

Authors

Xiao-Wei Zhang

Ya-Ping Sheng

Qian Li

Wei Qin

You-Wei Lu

Yu-Fan Cheng

Bing-Ya Liu

Feng-Chun Zhang

Jin Li

Goberdhan P Dimri

Wei-Jian Guo

Affiliations

Soon will be listed here.

Abstract

Background: The BMI1 oncogene is overexpressed in several human malignancies including gastric cancer. In addition to BMI1, mammalian cells also express Mel-18, which is closely related to BMI1. We have reported that Mel-18 functions as a potential tumor suppressor by repressing the expression of BMI1 and consequent downregulation of activated AKT in breast cancer cells. However, the mechanisms of BMI1 overexpression and the role of Mel-18 in other cancers are still not clear. The purpose of this study is to investigate the role of BMI1 and Mel-18 in gastric cancer.

Results: BMI1 was found to be overexpressed in gastric cancer cell lines and gastric tumors. Overexpression of BMI1 correlated with advanced clinical stage and lymph node metastasis; while the expression of Mel-18 negatively correlated with BMI1. BMI1 but not Mel-18 was found to be an independent prognostic factor. Downregulation of BMI1 by Mel-18 overexpression or knockdown of BMI1 expression in gastric cancer cell lines led to upregulation of p16 (p16INK4a or CDKN2A) in p16 positive cell lines and reduction of phospho-AKT in both p16-positive and p16-negative cell lines. Downregulation of BMI1 was also accompanied by decreased transformed phenotype and migration in both p16- positive and p16-negative gastric cancer cell lines.

Conclusions: In the context of gastric cancer, BMI1 acts as an oncogene and Mel-18 functions as a tumor suppressor via downregulation of BMI1. Mel-18 and BMI1 may regulate tumorigenesis, cell migration and cancer metastasis via both p16- and AKT-dependent growth regulatory pathways.

Citing Articles

Implication of protein post translational modifications in gastric cancer.

Song H, Zhang M, Guo C, Guo X, Ma Y, Ma Y Front Cell Dev Biol. 2025; 13:1523958.

PMID: 39968176 PMC: 11833226. DOI: 10.3389/fcell.2025.1523958.

Sustained inactivation of the Polycomb PRC1 complex induces DNA repair defects and genomic instability in epigenetic tumors.

Rawal C, Loubiere V, Butova N, Gracia J, Parreno V, Merigliano C Histochem Cell Biol. 2024; 162(1-2):133-147.

PMID: 38888809 PMC: 11227471. DOI: 10.1007/s00418-024-02302-z.

Sustained inactivation of the Polycomb PRC1 complex induces DNA repair defects and genomic instability in epigenetic tumors.

Rawal C, Loubiere V, Butova N, Garcia J, Parreno V, Martinez A Res Sq. 2024; .

PMID: 38746379 PMC: 11092839. DOI: 10.21203/rs.3.rs-4289524/v1.

Polycomb repressive complex 1 modulates granulosa cell proliferation in early folliculogenesis to support female reproduction.

Gao M, Zhang T, Chen T, Chen Z, Zhu Z, Wen Y Theranostics. 2024; 14(4):1371-1389.

PMID: 38389850 PMC: 10879878. DOI: 10.7150/thno.89878.

Evaluation of miR-330-3p and BMI1 Expression in Colorectal Cancer Patients, Healthy Adjacent Tissues, and Polypoid Adenomatous Lesions.

Basiri P, Afshar S, Amini R, Soltanian A, Saidijam M, Mahdavinezhad A Int J Mol Cell Med. 2023; 11(4):334-345.

PMID: 37727645 PMC: 10506674. DOI: 10.22088/IJMCM.BUMS.11.4.334.

References

Tetsu O, Ishihara H, Kanno R, Kamiyasu M, Inoue H, Tokuhisa T . mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25. Immunity. 1998; 9(4):439-48. DOI: 10.1016/s1074-7613(00)80627-5. View

Fu Z, Ma Z, Wang Q, Lei D, Wang R, Liu C . Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis. 2008; 25(8):887-92. DOI: 10.1007/s10585-008-9207-x. View

Guo W, Datta S, Band V, Dimri G . Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell. 2006; 18(2):536-46. PMC: 1783768. DOI: 10.1091/mbc.e06-05-0447. View

Qin Z, Yang J, Ye Y, Zhang X, Xu L, Zhou F . Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer. 2009; 9:61. PMC: 2652492. DOI: 10.1186/1471-2407-9-61. View

Datta S, Hoenerhoff M, Bommi P, Sainger R, Guo W, Dimri M . Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res. 2007; 67(21):10286-95. PMC: 2424172. DOI: 10.1158/0008-5472.CAN-07-1636. View

Gil J, Bernard D, Peters G . Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol. 2005; 24(2):117-25. DOI: 10.1089/dna.2005.24.117. View

Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003; 423(6937):255-60. DOI: 10.1038/nature01572. View

Schulz P, Scholz A, Rexin A, Hauff P, Schirner M, Wiedenmann B . Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis. Br J Cancer. 2008; 99(1):110-7. PMC: 2453030. DOI: 10.1038/sj.bjc.6604457. View

Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C . Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007; 121(8):1764-70. DOI: 10.1002/ijc.22891. View

10.

Kim E, Yun S, Do K, Kim M, Cho M, Suh D . Lysophosphatidic acid induces cell migration through the selective activation of Akt1. Exp Mol Med. 2008; 40(4):445-52. PMC: 2679274. DOI: 10.3858/emm.2008.40.4.445. View

11.

Dimri G . What has senescence got to do with cancer?. Cancer Cell. 2005; 7(6):505-12. PMC: 1769521. DOI: 10.1016/j.ccr.2005.05.025. View

12.

Liu J, Song L, Zhang X, Guo B, Feng Y, Li X . Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol. 2007; 97(3):267-72. DOI: 10.1002/jso.20934. View

13.

Wang Q, Li W, You P, Su J, Zhu M, Xie D . Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells. J Cell Biochem. 2008; 106(1):16-24. DOI: 10.1002/jcb.21969. View

14.

Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S . MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009; 69(23):9090-5. PMC: 2859686. DOI: 10.1158/0008-5472.CAN-09-2552. View

15.

Dimri G, Itahana K, Acosta M, Campisi J . Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol. 1999; 20(1):273-85. PMC: 85083. DOI: 10.1128/MCB.20.1.273-285.2000. View

16.

Wang W, Lin T, Huang J, Hu W, Xu K, Liu J . Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features. Urol Oncol. 2009; 29(3):244-51. DOI: 10.1016/j.urolonc.2009.02.004. View

17.

Zhao J, Luo X, Da C, Xin Y . Clinicopathological significance of B-cell-specific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion. World J Gastroenterol. 2009; 15(17):2145-50. PMC: 2678586. DOI: 10.3748/wjg.15.2145. View

18.

Luo D, Zhang B, Lv L, Xiang S, Liu Y, Ji J . Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest. 2006; 86(6):591-8. DOI: 10.1038/labinvest.3700415. View

19.

Godlewski J, Nowicki M, Bronisz A, Williams S, Otsuki A, Nuovo G . Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008; 68(22):9125-30. DOI: 10.1158/0008-5472.CAN-08-2629. View

20.

Dimri G, Martinez J, Jacobs J, Keblusek P, Itahana K, van Lohuizen M . The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 2002; 62(16):4736-45. View